A leader in CNS specialty medicine sales in the United States and in the top five globally, Teva Pharmaceuticals is actively looking to expand its CNS portfolio further.

Global Central Nervous System Therapeutics Market is valued at approximately USD 143.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.5% over the forecast period ...

examination, and medical decision-making. The manual defines medical decision-making as diagnosing and selecting management options. Analyze whether the service the CNS provides or wishes to ...